Botswana vs Canada: Previously treated cases tested for RR-/MDR-TB
Botswana
87.0%
in 2024
Canada
88.0%
in 2024
Botswana rank
92nd
Canada rank
90th
Previously treated cases tested for RR-/MDR-TB over time
- Botswana
- Canada
How they compare
Canada currently reports 88.0% against 87.0% in Botswana, a difference of 1.0%.
The two have swapped places 2 times across 11 shared years of data; in 2008 it was Canada ahead.
Botswana ranks 92nd and Canada ranks 90th of 180 countries.
Across the 3 decades both report, Botswana averaged higher in 1 and Canada in 2.
Head to head by decade
| Decade | Botswana | Canada | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.5% | 74.5% | 50.0% | Canada |
| 2010s | 9.6% | 76.3% | 66.7% | Canada |
| 2020s | 93.5% | 69.0% | 24.5% | Botswana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Botswana or Canada?
- Canada, at 88.0% against 87.0% in Botswana as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Botswana and Canada?
- 1.0%, with Canada ahead.
- How many years of comparable data are there for Botswana and Canada?
- 11 years are reported by both, from 2008 to 2024.
- How do Botswana and Canada rank globally for previously treated cases tested for rr-/mdr-tb?
- Botswana ranks 92nd and Canada ranks 90th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.